Lisanti Capital Growth’s Loxo Oncology, Inc LOXO Stock Holding History

Lisanti Capital Growth’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-6,650	Closed	-$931K	–	138
2018 Q4	$931K	Sell	6,650 -5,895	-47%	-$895K	0.38%	80
2018 Q3	$2.14M	Buy	12,545 +4,165	+50%	+$700K	0.74%	63
2018 Q2	$1.45M	Buy	+8,380	New	+$1.26M	0.56%	76

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Lisanti Capital Growth's LOXO Position: Q1 2019 in Review

Lisanti Capital Growth sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 6,650 shares — an estimated $931K sold.

Lisanti Capital Growth first reported a position in LOXO in Q2 2018 and held it in 3 quarters. The position peaked at $2.14M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Lisanti Capital Growth reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Lisanti Capital Growth sold 6,650 Loxo Oncology, Inc shares in Q1 2019, an estimated $931K.
Lisanti Capital Growth first reported a position in Loxo Oncology, Inc in Q2 2018 and held it in 3 quarters.
Lisanti Capital Growth's Loxo Oncology, Inc position peaked at $2.14M in Q3 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Lisanti Capital Growth's 13F filing for Q1 2019, filed 13 May 2019.